DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	CP-320650-01	None	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	CP-320650-01	None	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	CP-320650-01	None	drug-path
Adherens junction	R-HSA-451386	map04520	piribedil	4850	drug-path
Olfactory transduction	R-HSA-9751605	map04740	piribedil	4850	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	piribedil	4850	drug-path
Jak-STAT signaling pathway	R-HSA-168638	map04630	piribedil	4850	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	piribedil	4850	drug-path
Olfactory transduction	R-HSA-9751605	map04740	fluvoxamine	5324346	drug-path
Axon guidance	R-HSA-422475	map04360	fluvoxamine	5324346	drug-path
Epithelial cell signaling in Helicobacter pylori infection	0	map05120	fluvoxamine	5324346	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	fluvoxamine	5324346	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	fluvoxamine	5324346	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	fluvoxamine	5324346	drug-path
Prostate cancer	R-HSA-2990872	map05215	fluvoxamine	5324346	drug-path
TGF-beta signaling pathway	R-HSA-168638	map04350	fluvoxamine	5324346	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	fluvoxamine	5324346	drug-path
Endometrial cancer	R-HSA-2077421	map05213	fluvoxamine	5324346	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	fluvoxamine	5324346	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	etofenamate	35375	drug-path